Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02938494 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris
A Phase 2 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 2
- Development phase
- 210
- Enrollment target
NCT02938494 is a Phase 2 study that has completed, run by Bausch Health Americas. The registered enrollment target is 210 participants.
The verdict
NCT02938494, a Phase 2 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 210 participants
- Enrollment target
Study Summary
Safety and Efficacy of IDP-123 Lotion (0.045% tazarotene) to Tazorac® (tazarotene) Cream, 0.1%, in the Treatment of Acne Vulgaris
Interventions
- DRUG Vehicle Cream
- DRUG Vehicle Lotion
- DRUG Tazorac Cream
- DRUG IDP-123 Lotion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02938494
The ClinicalTrials.gov registry entry for NCT02938494 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Vehicle Cream is the first listed.
NCT02938494 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02938494 about?
NCT02938494 is a clinical study titled "Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris". Safety and Efficacy of IDP-123 Lotion (0.045% tazarotene) to Tazorac® (tazarotene) Cream, 0.1%, in the Treatment of Acne Vulgaris
What is the current status of trial NCT02938494?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 210 participants. The study started on 2015-11. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02938494?
The interventions under investigation include: Vehicle Cream (DRUG), Vehicle Lotion (DRUG), Tazorac Cream (DRUG), IDP-123 Lotion (DRUG).
Who is sponsoring clinical trial NCT02938494?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.